About Evidera
Evidera is a Healthcare company based in Bethesda (United States) founded in 2012, and was acquired by PPD in September 2016. Evidence-based solutions are provided for biopharmaceutical real-world effectiveness and safety. The company has 304 employees. Evidera has completed 2 acquisitions, including GenerasiTogel and Medimix International. Evidera offers products and services including Real-World Evidence Solutions, Patient-Centered Research, and Strategic Development Consulting. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its legal entity is EVIDERA, INC. Its competitors include SSI Strategy, Health Decisions and Antios Therapeutics; 1 of its 3 listed competitors has raised funding.
Company details
Evidera, acquired by PPD in 2016 is a provider of evidence-based solutions to demonstrate real-world effectiveness and safety of biopharmaceutical products right from early development stages to right until loss of exclusivity. The companys core expertise lies in areas such as health economics, outcomes research, market access, epidemiology, and data analytics. The company offers its services for interventional studies, patient-centred research, pragmaticadaptive studies, modelling and meta-research, market access and medical writing. The companys proprietary software Evalytica, is a software for developing real-world evidence.
- Headquarters Bethesda, United States
- Employees 304
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website evidera.com
- Social LinkedIn X
- Acquired by PPD (Sep 2016)
- Legal Name Evidera, Inc.
- InvestorsSTG
& 1 more
- Employee Count304
- Investments & AcquisitionsGenerasiTogel
& 1 more
- Acquired by
Products & Services of Evidera
Evidera offers a comprehensive portfolio of products and services, including Real-World Evidence Solutions, Patient-Centered Research, and Strategic Development Consulting.
Generates insights from real-world data for drug development and approval.
Reduces patient burden in clinical trials for better recruitment.
Provides tailored strategies for regulatory and clinical needs.
Investors in Evidera
Evidera has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include STG and PPD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A private equity firm focused on mid-market software leaders. | 1990 | stg.com | Menlo Park, United States | |
CRO providing diversified clinical development services | 1985 | ppd.com | Wilmington, United States |
Investor details for Evidera
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Evidera
199 people are tracked at Evidera (33 in leadership, 166 in team); the tracked headcount is 304.
| Name | Role | Group |
|---|---|---|
Alessandro Terra Palhares | Managing Director RWDS | Leadership |
Caroline Delaitre-Bonnin | Executive Director Value And Access | Leadership |
Ariel Berger | Executive Director, Integrated Solutions, Real-world Evidence | Leadership |
Venediktos Kapetanakis | Senior Director Statistics | Leadership |
Shannon Sullivan | Senior Director, Research Scientist-evidence Synthesis, Modeling, Market Access Communication-global | Leadership |
Jennifer Whitty | Senior Director Research Science | Leadership |
Heather Gelhorn | Vice President - Science | Leadership |
Malinda O'Donnell | Vice President, Market Access Communication | Leadership |
Tracy Farrow | Executive Director, Medical Writing And Healthcare Communications | Leadership |
Marie Andrawes | Director, Market Access Communications | Leadership |
Minh Luu | Associate Director, Market Access Communications | Leadership |
Foster Rockwell | Director, Enterprise Learning | Leadership |
Thomas Baker | Vice President Of Technology | Leadership |
Kathy Fraeman | Director, Data Analytics And Principal Data Analyst At Evidera | Leadership |
Mariya Bekirska | Associate Director, Project Management (real World Evidence Solutions) | Leadership |
Beth Nordstrom | Senior Research Leader And Executive Director, Epidemiology | Leadership |
Dimitra Lambrelli | Senior Director And Senior Research Scientist, Real World Evidence | Leadership |
Firas Dabbous | Director-senior Research Scientist | Leadership |
Christopher Pelligra | Senior Director, Research Science | Leadership |
Karin Coyne | Vice President Research | Leadership |
179 more people are available in the full profile.
Complete people profiles for Evidera
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Evidera
Evidera has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include GenerasiTogel and Medimix International.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Business intelligence software is provided to pharmaceutical and diagnostics sectors. | medimix.net | Miami, United States | 1990 | May 2019 | •••• | |
Human physiology, diseases, and healthcare systems are modeled for simulations. | archimedesmodel.com | San Francisco, United States | 2006 | Jan 2014 | •••• |
Complete acquisition details for Evidera
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Evidera
5 dated milestones of Evidera across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Evidera is founded.
- Exit Acquired by STG.
- Acquisition Acquires GenerasiTogel.
- Exit Acquired by PPD.
- Acquisition Acquires Medimix International.
Competitors of Evidera
Evidera has 3 listed competitors in our database, 1 of them funded. They include SSI Strategy, Health Decisions and Antios Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ssistrategy.com | 2010 | Parsippany Troy Hills, United States | Pharmacovigilance and medical affairs services are offered for drug development. | |||
| healthdec.com | 1989 | Durham, United States | 110 | CRO focused on clinical trial services for data management, monitoring and biostatistics | ||
| antiostherapeutics.com | 2018 | Atlanta, United States | $200.4M | Innovative therapies for treating and curing viral diseases are developed. |
Detailed competitors of Evidera
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Evidera
Websites that share an audience with Evidera (evidera.com).
- Unique visitors1.1K
per month
- Global rank#7,353,754
among all websites
- Category rank#6,985
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit1.4
- Average visit8 sec
- DevicesDesktop 8% · Mobile 92%
Websites whose visitors overlap most with Evidera. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| scilife.io | 100% | 99.9K | #436,534 | View details | |
 onbiostatistics.blogspot.com | onbiostatistics.blogspot.com | 82% | #3,045,045 | – | |
skillsforhealth.org.uk | skillsforhealth.org.uk | 76% | #617,270 | – | |
| medtecheurope.org | 68% | 55.3K | #653,155 | View details | |
| hrb.ie | 64% | 40.8K | #395,770 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Evidera
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Evidera (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Evidera
Complete news archive for Evidera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Evidera
Evidera was founded in 2012.
Evidera is headquartered in Bethesda, United States. It is registered at Bethesda, Maryland, United States.
Evidera has 304 employees.
Evidera, acquired by PPD in 2016 is a provider of evidence-based solutions to demonstrate real-world effectiveness and safety of biopharmaceutical products right from early development stages to right until loss of exclusivity. The companys core expertise lies in areas such as health economics, outcomes research, market access, epidemiology, and data analytics. The company offers its services for interventional studies, patient-centred research, pragmaticadaptive studies, modelling and meta-research, market access and medical writing. The companys proprietary software Evalytica, is a software for developing real-world evidence.
Evidera's top competitors include SSI Strategy, Health Decisions and Antios Therapeutics.
Evidera offers Real-World Evidence Solutions, Patient-Centered Research, and Strategic Development Consulting.
Evidera has made 2 acquisitions, including GenerasiTogel, and Medimix International.
Evidera operates through Evidera, Inc..
Yes. Evidera was acquired by PPD in September 2016.